INKT CIK: 1840229

MiNK Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−28.4
FY22:
−30.9
FY23:
−22.9
FY24:
−11.3
FY25:
−12.6
(positive)
Change from FY21 to FY23
millions USD
FY21:
−28.6
FY22:
−30.8
FY23:
−22.7
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY23
millions USD
FY21:
−30.2
FY22:
−28.0
FY23:
−22.5
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−30.2
FY22:
−28.0
FY23:
−22.5
FY24:
−10.8
FY25:
−12.5

All amounts in millions USD Data sources:SEC EDGARTwelve Data